Quantum Genesis AI (QTZM) Equity Average (2016 - 2026)
Quantumzyme's Equity Average history spans 6 years, with the latest figure at -$454463.5 for Q1 2026.
- For Q1 2026, Equity Average fell 26.87% year-over-year to -$454463.5; the TTM value through Jan 2026 reached -$454463.5, down 26.87%, while the annual FY2025 figure was -$362008.0, 148.1% down from the prior year.
- Equity Average reached -$454463.5 in Q1 2026 per QTZM's latest filing, up from -$465651.0 in the prior quarter.
- In the past five years, Equity Average ranged from a high of -$145911.5 in Q3 2024 to a low of -$465651.0 in Q4 2025.
- Average Equity Average over 3 years is -$363860.7, with a median of -$387834.5 recorded in 2025.
- Peak YoY movement for Equity Average: tumbled 188.96% in 2025, then dropped 26.87% in 2026.
- A 3-year view of Equity Average shows it stood at -$313310.5 in 2024, then tumbled by 48.62% to -$465651.0 in 2025, then grew by 2.4% to -$454463.5 in 2026.
- Per Business Quant, the three most recent readings for QTZM's Equity Average are -$454463.5 (Q1 2026), -$465651.0 (Q4 2025), and -$421629.0 (Q3 2025).